Logo

Protagen, Charles River Ink Protein Analysis Services Alliance

Oct 28, 2011

NEW YORK (GenomeWeb News) – Protagen announced today a protein analysis services alliance with Charles River Biopharmaceutical Services, the biologics testing and manufacturing business of Charles River Laboratories.

Under the agreement, Charles River will offer clients protein analytical services using Protagen's technology. Further terms of the alliance were not disclosed.

Protagen makes the UNIarray platform for developing serum-based diagnostics and the UNIchip portfolio of protein microarrays.

Filed under

Proteomics & Protein Research
Drug Discovery & Development
Microarrays & Multiplexing
Business News
services alliance
proteomics
drug screening
protein arrays
Protagen
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.